Renal Cell Carcinoma
Showing NaN - NaN of 48
Renal Cell Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Bevacizumab, Sunitinib)
Completed
- Renal Cell Carcinoma
- Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
- +2 more
-
Tucson, Arizona
- +153 more
Jan 13, 2022
Metastatic Castration-resistant Prostrate Cancer, Renal Cell Carcinoma, Metastatic Melanoma Trial in United States (BMS-936558
Completed
- Metastatic Castration-resistant Prostrate Cancer
- +3 more
- BMS-936558 (MDX-1106)
-
Scottsdale, Arizona
- +12 more
Dec 1, 2021
Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Pazopanib,
Completed
- Renal Cell Carcinoma
- Clear-cell Metastatic Renal Cell Carcinoma
- Nivolumab
- +3 more
-
Duarte, California
- +13 more
Nov 30, 2021
Colorectal Cancer Metastatic, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in Canada, United States (EDP1503,
Completed
- Colorectal Cancer Metastatic
- +6 more
- EDP1503
- Pembrolizumab
-
Rogers, Arkansas
- +7 more
Nov 11, 2021
Disease Burden and Biology Using Tumor Cell Free DNA in
Recruiting
- Renal Cell Carcinoma
- Blood collection
- Urine collection
-
Nashville, Tennessee
- +2 more
Sep 1, 2021
Renal Cell Carcinoma Trial in Worldwide (Cabozantinib tablets, Everolimus (Afinitor) tablets)
Completed
- Renal Cell Carcinoma
- Cabozantinib tablets
- Everolimus (Afinitor) tablets
-
Birmingham, Alabama
- +204 more
Apr 1, 2021
Advanced Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Boston, New York, Nashville
Completed
- Advanced Cancer
- +5 more
-
Boston, Massachusetts
- +3 more
Nov 24, 2020
Renal Cell Carcinoma Trial in Worldwide (TRC105 and Axitinib, Axitinib)
Terminated
- Renal Cell Carcinoma
- TRC105 and Axitinib
- Axitinib
-
Birmingham, Alabama
- +38 more
Oct 15, 2020
Renal Cell Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody, Bevacizumab, Sunitinib)
Completed
- Renal Cell Carcinoma
- Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
- +2 more
-
Scottsdale, Arizona
- +44 more
Dec 19, 2019
Renal Cell Carcinoma Trial in Ann Arbor, Cleveland, Nashville (Lenalidomide, Sunitinib)
Terminated
- Renal Cell Carcinoma
-
Ann Arbor, Michigan
- +2 more
Nov 14, 2019
Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (Standard Treatment,
Terminated
- Advanced Renal Cell Carcinoma
- +2 more
- Standard Treatment
- AGS-003
-
Scottsdale, Arizona
- +124 more
Jun 13, 2018
Renal Cell Carcinoma, Kidney Cancer Trial in Boston, Nashville (bevacizumab, temsirolimus)
Completed
- Renal Cell Carcinoma
- Kidney Cancer
-
Boston, Massachusetts
- +2 more
Jan 1, 2018
Renal Cell Carcinoma Trial in Worldwide (Bevacizumab, Temsirolimus, Interferon-Alfa 9MU)
Renal Cell Carcinoma Trial in United States (Pazopanib)
Completed
- Renal Cell Carcinoma
-
San Francisco, California
- +16 more
May 18, 2015
Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma
Completed
- Renal Cell Carcinoma
-
Jonesboro, Arkansas
- +7 more
Nov 12, 2013
Renal Cell Carcinoma Trial in Worldwide (autologous human tumor-derived HSPPC-96)
Completed
- Renal Cell Carcinoma
- autologous human tumor-derived HSPPC-96
-
Anchorage, Alaska
- +75 more
Sep 6, 2012